Topical Skin Infection Treatment Market to Grow at a CAGR of 5.20% During 2024-2032, Aided by the Rising Prevalence of Skin Infections Across the 8 Major Markets

Topical Skin Infection Treatment Market Overview

Skin infections are caused by various pathogens, including bacteria causing cellulitis and impetigo, and viruses responsible for warts and shingles, among others. Common symptoms of a skin infection are swelling, pain, rashes, pus, redness, and itching. The rising cases of skin infections are one of the key drivers of the topical skin infection treatment market, pushing the demand for over-the-counter (OTC) and prescription topical treatments. The growing awareness of skin infections and the growth in online channels are expected to elevate the market value. Further, the rising consumer inclination towards natural and organic treatments for skin infections are likely to expand the product range and stimulate market innovation during the forecast period.

Key Findings

• Recent data suggests that skin conditions affect around 1.8 billion individuals at any point in time. The increasing burden of skin infections is one of the primary factors driving the market demand for topical treatments.
• In December 2023, ZORYVE (roflumilast) topical foam, 0.3%, a once-daily steroid-free foam developed by an early commercial-stage biopharmaceutical company Arcutis Biotherapeutics, Inc., was granted approval by the United States Food and Drug Administration (FDA) for the treatment of seborrheic dermatitis, a non-contagious skin condition, in patients aged 9 years and above. The surge in the regulatory approvals of innovative topical treatments is set to fuel market growth.
• The rising availability of over-the-counter topical treatments for skin infections in retail pharmacies and online platforms is a significant market trend.

Topical Skin Infection Treatment Market Demand Drivers

According to the World Health Organization (WHO), around 1.8 billion people are affected by skin conditions at any point in time. Skin infections caused by viral, bacteria, fungi, or parasites, are counted among the most common causes of the disease in tropical and resource-poor settings. Various studies reveal that skin-related neglected tropical diseases comprise 10% of all skin diseases in most communities. The increasing prevalence of skin infections, propelled by factors such as poor hygiene, growing urbanization, and changes in environmental conditions, is boosting the market demand for topical treatments.

Topical Skin Infection Treatment Market Segmentation Analysis

The Product Type Segment is Set to Experience Significant Growth in the Forecast Period

Based on the product type, the market segmentation includes creams, gel, lotions, powder, and others. Topical creams are commonly used to treat various skin infections, including fungal, bacterial, and viral infections. The cream segment experiences significant demand due to its properties of better absorption, easy application, and effective action on localized infections. The rising innovations in cream formulations, such as the incorporation of moisturizers or anti-inflammatory agents, are expected to augment the growth of this segment in the coming years.

The market report also offers insights based on category, type, end user, distribution channel, and region.

Topical Skin Infection Treatment Market: Competitive Landscape

• In April 2024, Dermavant Sciences, a specialty biopharmaceutical company focused on dermatologic diseases, reported that its Supplemental New Drug Application (sNDA) for non-steroidal tapinarof cream, 1% (VTAMA cream) indicated for the treatment of atopic dermatitis in both adults and children that are aged 2 years and above was accepted by the US Food and Drug Administration (FDA).
• in January 2024, Ligand Pharmaceuticals Incorporated, a California-based biopharmaceutical company, announced the FDA approval of its topical prescription medication ZELSUVMI™ (berdazimer topical gel, 10.3%) to treat a viral skin infection, molluscum contagiosum, in adults and pediatric patients aged one year and above.
• Other players involved in the market include Mölnlycke Health Care AB, Coloplast Corp, Johnson and Johnson, Inc., Smith+Nephew, Convatec Inc., Cardinal Health, Dynarex Corporation, MIMEDX Group Inc., and 3M.

Topical Skin Infection Treatment Market Analysis by Region

The United States is Likely to Lead the Market Share

The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States covers a substantial share of the market owing to the widespread availability of both prescription and over-the-counter topical treatments for skin infections in the country. The presence of key pharmaceutical companies and significant investments in research and development to advance topical formulations are poised to boost market growth. Additionally, the rising preference for natural and organic skin infection treatments is likely to shape the market landscape in the region.

Key Offerings of the Report

• The EMR report gives an overview of the market for topical skin infection treatment for the time span of (2017-2023) and (2024-2032).
• The report also offers historical (2017-2023) and forecast (2024-2032) market information for the product type, category, type, end user, distribution channel, and region of the market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790